Eden Innovations Ltd

EDE · Oil, Gas & Consumable Fuels · Australia

Profile

TickerEDE

RICEDE.AX

ISINAU000000EDE1

IssuerEden Innovations Ltd

SectorEnergy

IndustryOil, Gas & Consumable Fuels

Sub-industryConstruction Materials

HeadquartersPerth, Australia

Country of issuerAustralia

Founded2004-05-21

Employees—

Total share float245,217,529

Holders (C/S)—

AuditorNexia Perth Audit Services Pty Ltd

CEO / managementMr. Gregory Howard (Greg) Solomon

Business Description

Eden Innovations Ltd produces and sells a high-performance concrete admixture, EdenCrete and retrofit dual fuel technology, OptiBlend developed for diesel generator sets. Its segments include Eden Innovations LLC and Eden Innovations (India) Pvt Ltd. Eden Innovations LLC segment includes EdenCrete sales and development and Optiblend sales, service, and manufacturing in the United States. The Eden Innovations (India) Pvt Ltd segment includes Optiblend sales, service, and manufacturing in India. The Company’s innovations include EdenCrete, OptiBlend, EdenPlast, and Other Technologies. Its EdenCrete is a carbon nanotube enriched admixture for concrete that improves tensile and flexural strength. Its OptiBlend technology allows a conventional diesel engine to run natural gas as its primary fuel without modifying the engine or the current diesel fuel system. Its EdenPlast is a CNT enriched polypropylene tape. Its other technologies are Pyrolysis Project and Hythane.

ESG · Risk Indicators

Controversies score—

Governance pillar—

Social pillar—

Insider trading score—

Industry Substrate · Materials

Signals to watch

Construction starts / housing permits (leading)
Commodity input price spreads (coincident)
Capacity utilization (coincident)
Trade-flow shifts / import competition (trend)

Geopolitical drivers

Trade tariffs (US-China steel/cement) · exposure: high
Energy cost / carbon-pricing exposure · exposure: high (cement)
Supply chain bottlenecks (forestry, paper pulp) · exposure: medium

Industry KPIs

EBITDA per ton — core unit economic
Capacity utilization % — 75-85% healthy
Net debt / EBITDA — below 3.5x given cyclicality
ROIC through-cycle — 8-12% acceptable

Full Analysis Pending

Detailed financial analysis, valuation snapshot, multi-period history, and AI narrative are pending — generated when this company is included in the next analysis batch. Profile data above is point-in-time as of 2026-04-30.